Research graph
References from Fractional exhaled nitric oxide and blood eosinophils in relation to lung function, allergy and nasal polyps in asthma. Local targets link to admitted publications; unresolved targets remain external evidence.
The prevalence of subtypes of type 2 inflammation in an unselected population of patients with severe asthma
10.1016/j.jaip.2020.09.051 · 2021 · External reference
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
10.1186/s13601-019-0282-7 · 2019 · External reference
Simultaneously increased fraction of exhaled nitric oxide levels and blood eosinophil counts relate to increased asthma morbidity
10.1016/j.jaci.2016.01.044 · 2016 · External reference
Toward a predict and prevent approach in obstructive airway diseases
10.1016/j.jaip.2023.01.008 · 2023 · External reference
Associations between blood eosinophils and decline in lung function among adults with and without asthma
10.1183/13993003.02536-2017 · 2018 · External reference
Fractional exhaled nitric oxide nonsuppression identifies corticosteroid-resistant type 2 signaling in severe asthma
10.1164/rccm.202104-1040le · 2021 · External reference
IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells
10.1111/j.1365-2222.2008.02969.x · 2008 · External reference
Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma
10.1056/nejmoa1804092 · 2018 · External reference
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
10.1016/s0140-6736(12)60988-x · 2012 · External reference
Unresolved reference
External reference
Blood eosinophil reference values and determinants in a representative adult population
2025 · External reference
Sub-stratification of type-2 high airway disease for therapeutic decision-making: a ‘bomb’ (blood eosinophils) meets 'magnet' (FeNO) framework
10.1111/resp.14294 · 2022 · External reference
Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects
10.1016/j.jaci.2013.06.007 · 2013 · External reference
Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide
10.1136/thoraxjnl-2021-217325 · 2022 · External reference
Cohort profile: the West Sweden Asthma Study (WSAS): a multidisciplinary population-based longitudinal study of asthma, allergy and respiratory conditions in adults
10.1136/bmjopen-2018-027808 · 2019 · External reference
Asthma remission in adults: role of age at asthma onset, smoking, obesity, and allergic rhinitis
10.1111/all.70106 · 2026 · External reference
Adult-onset compared to childhood-onset asthma: multifaceted symptoms, comorbidity, and healthcare burden
10.1002/clt2.70160 · 2026 · External reference
Lifetime asthma incidence is related to age at onset and allergies in western Sweden
10.1002/clt2.70015 · 2024 · External reference
Obesity and weight change during eight years in relation to asthma incidence
10.1038/s41598-025-20657-8 · 2025 · External reference
Reference values and determinants of fractional exhaled nitric oxide in a representative adult population in Western Sweden
10.1002/clt2.70107 · 2025 · External reference
ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005
10.1164/rccm.200406-710st · 2005 · External reference
A European Respiratory Society technical standard: exhaled biomarkers in lung disease
10.1183/13993003.00965-2016 · 2017 · External reference
Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society Technical Statement
10.1164/rccm.201908-1590st · 2019 · External reference
Standardisation of spirometry
10.1183/09031936.05.00034805 · 2005 · External reference
Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations
10.1183/09031936.00080312 · 2012 · External reference
High eosinophil counts predict decline in FEV1: results from the CanCOLD study
10.1183/13993003.00838-2020 · 2021 · External reference
Type-2 inflammation and lung function decline in chronic airway disease in the general population
10.1136/thorax-2023-220972 · 2024 · External reference
Predictors of accelerated decline in lung function in adult-onset asthma
10.1183/13993003.01785-2017 · 2018 · External reference
FEV(1) decline in relation to blood eosinophils and neutrophils in a population-based asthma cohort
10.1016/j.waojou.2020.100110 · 2020 · External reference
Blood eosinophil count as a predictor of lung function decline in healthy individuals
10.1016/j.jaip.2020.07.055 · 2021 · External reference
Longitudinal variability of blood eosinophils impact lung function decline in the general population
10.1183/23120541.00368-2025 · 2025 · External reference
Persistently high exhaled nitric oxide and loss of lung function in controlled asthma
10.1016/j.alit.2015.12.006 · 2016 · External reference
Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma
10.1183/09031936.00135907 · 2008 · External reference
Bronchodilator response and lung function decline: associations with exhaled nitric oxide with regard to sex and smoking status
10.1016/j.waojou.2021.100544 · 2021 · External reference
An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FeNO) for clinical applications
10.1164/rccm.9120-11st · 2011 · External reference
Evaluation of airway hyperresponsiveness and exhaled nitric oxide as risk factors for airway remodeling in patients with stable asthma
10.2500/aap.2009.30.3253 · 2009 · External reference
Type 2 biomarkers and prediction of future exacerbations and lung function decline in adult asthma
10.1016/j.jaip.2018.03.004 · 2018 · External reference
Increase in blood eosinophil count over time and sputum IL8 are associated with FEV(1) decline in asthma
10.1007/s00408-024-00760-9 · 2024 · External reference
Association between exhaled nitric oxide and nasal polyposis in severe asthma
10.1016/j.rmed.2019.04.017 · 2019 · External reference
The impact of blood eosinophil count and FeNO on benralizumab effectiveness in clinical practice: an ORBE II subanalysis
10.1016/j.rmed.2025.107940 · 2025 · External reference
Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial
10.1001/jama.2015.19330 · 2016 · External reference
Distribution of type 2 biomarkers and association with severity, clinical characteristics and comorbidities in the BREATHE real-life asthma population
10.1183/23120541.00483-2022 · 2023 · External reference
Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide, and their combination in severe asthma: a post hoc analysis
10.1164/rccm.201903-0599le · 2019 · External reference
